Connection

Kenneth Tew to Alzheimer Disease

This is a "connection" page, showing publications Kenneth Tew has written about Alzheimer Disease.
Connection Strength

0.684
  1. ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target. Biochem Pharmacol. 2018 05; 151:188-200.
    View in: PubMed
    Score: 0.401
  2. Association of ABCA2 expression with determinants of Alzheimer's disease. FASEB J. 2004 Jul; 18(10):1129-31.
    View in: PubMed
    Score: 0.157
  3. ABCA2 as a therapeutic target in cancer and nervous system disorders. Expert Opin Ther Targets. 2008 Apr; 12(4):491-504.
    View in: PubMed
    Score: 0.051
  4. The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds. Curr Drug Metab. 2007 Jan; 8(1):47-57.
    View in: PubMed
    Score: 0.047
  5. Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-? production by altering Nicastrin maturation and intracellular localization. J Biol Chem. 2012 Jan 06; 287(2):1100-11.
    View in: PubMed
    Score: 0.016
  6. The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking. Biomed Pharmacother. 2006 Nov; 60(9):587-92.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.